Is There a Relationship Between Use of Anti-Vascular Endothelial Growth Factor Agents and Atrophic Changes in Age-Related Macular Degeneration Patients?
Choroidal neovascularization due to age-related macular degeneration (AMD) is currently treated successfully with anti-vascular endothelial growth factor (VEGF) intravitreal agents. Emerging evidence suggests that anti-VEGF treatment may potentially increase development of geographic atrophy. Howeve...
Main Authors: | Süleyman Kaynak, Mahmut Kaya, Derya Kaya |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2018-04-01
|
Series: | Türk Oftalmoloji Dergisi |
Subjects: | |
Online Access: | http://www.oftalmoloji.org/archives/archive-detail/article-preview/s-there-a-relationship-between-use-of-anti-vascula/17059 |
Similar Items
-
Screening of cytokines in blood serum and lacrimal liquid in wet and atrophic forms of age-related macular degeneration
by: V. V. Neroev, et al.
Published: (2022-03-01) -
Suspension of Anti-VEGF Treatment Does Not Affect Expansion of RPE Atrophy in Neovascular Age-Related Macular Degeneration
by: Shinichiro Chujo, et al.
Published: (2023-05-01) -
Exudative versus Nonexudative Age-Related Macular Degeneration: Physiopathology and Treatment Options
by: Ana Rita Fernandes, et al.
Published: (2022-02-01) -
AGE- MACULAR DEGENERATION AND GLAUCOMA. EPIDEMIOLOGICAL AND CLINIC-PATHOGENETIC ASPECTS
by: A. Z. Fursova, et al.
Published: (2019-02-01) -
Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration
by: Kabanarou SA, et al.
Published: (2017-05-01)